Altimmune (ALT) Receivables (2010 - 2026)
Altimmune (ALT) reported Receivables of $3.1 million for Q1 2026, up 237.93% year-over-year from $907000.0 in Q1 2025, and up 32.17% quarter-over-quarter from $2.3 million in Q4 2025.
Altimmune (ALT) Receivables (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 17 years of Receivables data on file, last reported at $3.1 million in Q1 2026.
- Receivables for Q1 2026 came in at $3.1 million, up 237.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (up 237.93% YoY), and the FY2025 annual result was $2.3 million, up 145.66% from the prior year.
- Receivables rose to $3.1 million in Q1 2026 per ALT's latest filing, from $2.3 million in the prior quarter.
- Over five years, Receivables peaked at $3.1 million in Q1 2026 and troughed at $136000.0 in Q2 2023.
- A 5-year average of $866411.8 and a median of $724000.0 in 2024 frame the typical range for Receivables.
- The sharpest annual moves came in 2022 and 2023: Receivables slumped 95.98% in 2022, then jumped 600.0% in 2023.
- A 5-year view of Receivables shows it stood at $173000.0 in 2022, then jumped by 600.0% to $1.2 million in 2023, then slipped by 22.05% to $944000.0 in 2024, then surged by 145.66% to $2.3 million in 2025, then surged by 32.17% to $3.1 million in 2026.
- Business Quant data shows ALT's Receivables at $3.1 million in Q1 2026, $2.3 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | 3.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.07 Mn |
| Dec 31, 2025 | 2.32 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 321,000.00 |
| Mar 31, 2025 | 907,000.00 |
| Dec 31, 2024 | 944,000.00 |
| Sep 30, 2024 | 728,000.00 |
| Jun 30, 2024 | 724,000.00 |
| Mar 31, 2024 | 507,000.00 |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | 876,000.00 |
| Jun 30, 2023 | 136,000.00 |
| Mar 31, 2023 | 252,000.00 |
| Dec 31, 2022 | 173,000.00 |
| Sep 30, 2022 | 633,000.00 |
| Jun 30, 2022 | 195,000.00 |
| Mar 31, 2022 | 193,000.00 |
| Dec 31, 2021 | 429,000.00 |
| Sep 30, 2021 | 1.57 Mn |
| Jun 30, 2021 | 4.46 Mn |